Navigation Links
New Drug Found To Improve Driving Performance In Young Adults With ADHD

A new drug, ADDERALL XR? has been found to improve driving performance, cognitive function and attention in young adults with attention-deficit/hyperactivity disorder (ADHD).//

The result has been presented at the 18th Annual U.S. Psychiatric & Mental Health Congress in Las Vegas, NV and establishes that the drug helps young adults improve their ability to drive over a 12-hour period.

Accidents are the leading cause of death until age 40, the incidence of which is greater among adults with ADHD. Furthermore, the incidence of traffic violations and license suspensions is much greater than among patients with ADHD.

Infact, ADHD patients were five times more likely to have speeding tickets (5 or more) and three times more likely to succumb to vehicular clashes (thrice or more). This observation could be because of the fact that adolescent and adult patients often fail to appreciate the effect that ADHD symptoms such as inattention have on daily activities such as driving.

The researchers hence studied the effect of ADDERALL XR, a major ADHD therapy, on driving performance in young adult patients with ADHD. Participants received doses of ADDERALL XR at 20 milligrams (mg) for the first week and then increased to 40 mg and 50 mg for the second and third weeks, respectively.

All patients were evaluated for driving performance after the medication was administered. The STISIM was used to analyze the critical driving skills, including situation awareness, hazard perception, risk assessment and decision-making under time pressure.

Patients taking the drug demonstrated significant improvement in driving safety and performance compared to a placebo. Safety-related driving parameters, including speeding tickets, traffic tickets, crashes, crash avoidance rating, time to collision and excess speed were some of the factors taken into consideration during the assessment.

Furthermore, ADDERALL XR significantl y improved ADHD symptom control in young adults with ADHD as compared to those on placebo. Eighty percent of patients experienced at least a 30 percent reduction in their ADHD symptoms. It also had significant effects on the participants' attention, an important cognitive ability.

The majority of side effects during the trial were mild or moderate and consistent with known side effects of stimulant medications such as decreased appetite, weight loss, dry mouth, insomnia and bruxism (teeth grinding). These findings suggest that there is a carryover beneficial effect of having performed a mentally demanding task like driving. The effect would even be valuable when the individual is not taking the medication.
'"/>




Related medicine news :

1. Fluoride Found Effective in Osteoporosis
2. Implantable Contact Lens Found Safe and Effective
3. Cancer hazard Found With Animal-Based Nutrients
4. Processed Meat, Diabetes connection Found
5. Night Time Aspirin Regimen Found to Reduce Blood Pressure
6. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
7. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
8. Preventive Therapies Found to be More Effective in Managing Migraines
9. Common Cold Found to Fight Cancer
10. Circumcision Found To Prevent HIV Spread
11. Drug Found To Reduce The Transmission Of Herpes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... To succeed under value-based payments, ... are unsure how to move forward, given the need to sustain current operations. ... tailored to an organization’s specific needs. , PYA Principal Martie Ross states, “Healthcare ...
(Date:6/23/2016)... ... June 23, 2016 , ... Terumo BCT, ... organization responsible for clinical transfusion research programs and for the blood supply in ... Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently in its ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Calif. , June 24, 2016  American Respiratory Labs (ARL), ... is now able to perform sophisticated lung assessments in patients, homes, ... , Inc. Patients are no longer limited to ... EasyOne PRO ® , ARL patients like Jeanne R. of ... in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
Breaking Medicine Technology: